• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中靶向FOX家族治疗的进展

Progress of targeted FOX family therapy in ovarian cancer.

作者信息

Zhang Hairong, Gong Cuiping, Lv Xin

机构信息

Department of Obstetrics and Gynecology, Shandong Provincial Third Hospital, Shandong University, Ji'nan, China.

出版信息

Front Pharmacol. 2025 Jul 17;16:1604998. doi: 10.3389/fphar.2025.1604998. eCollection 2025.

DOI:10.3389/fphar.2025.1604998
PMID:40746724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12310647/
Abstract

Ovarian cancer (OC) remains one of the most lethal malignancies affecting women, largely due to its asymptomatic onset and the consequent challenges in early detection and diagnosis. This often results in delayed treatment and poor clinical outcomes. Among gynecological cancers, OC exhibits the highest mortality rate. While current therapeutic approaches such as surgery and chemotherapy provide initial clinical benefit, they are frequently undermined by high rates of recurrence and metastasis. Moreover, the pronounced heterogeneity of OC further complicates treatment, highlighting the urgent need for novel therapeutic targets and more effective strategies. The forkhead box (FOX) family of transcription factors comprises a large group of proteins involved in regulating gene expression across various biological processes. Dysregulation of FOX family members has been implicated in aberrant cellular behaviors, including uncontrolled proliferation, resistance to apoptosis, enhanced invasiveness, metastatic potential, and the development of drug resistance. Importantly, the functional roles of individual FOX proteins vary significantly depending on the tumor context, reflecting the functional diversity of this family. This review aims to provide a comprehensive overview of the emerging roles of FOX family members in the pathogenesis and progression of OC, as well as recent advances in FOX-targeted therapeutic strategies.

摘要

卵巢癌(OC)仍然是影响女性的最致命恶性肿瘤之一,这主要归因于其无症状发病以及早期检测和诊断方面随之而来的挑战。这常常导致治疗延迟和临床结果不佳。在妇科癌症中,OC的死亡率最高。虽然目前的治疗方法,如手术和化疗能带来初步的临床益处,但它们常常因高复发率和转移率而受到影响。此外,OC显著的异质性使治疗更加复杂,凸显了对新型治疗靶点和更有效策略的迫切需求。叉头框(FOX)转录因子家族由一大类参与调控各种生物学过程中基因表达的蛋白质组成。FOX家族成员的失调与异常的细胞行为有关,包括不受控制的增殖、对凋亡的抵抗、侵袭性增强、转移潜能以及耐药性的发展。重要的是,单个FOX蛋白的功能作用因肿瘤背景而异,这反映了该家族的功能多样性。本综述旨在全面概述FOX家族成员在OC发病机制和进展中的新作用,以及FOX靶向治疗策略的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/5e0a6f8bc7dc/fphar-16-1604998-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/600b51048107/fphar-16-1604998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/36350eec6b34/fphar-16-1604998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/cfc22045c2bb/fphar-16-1604998-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/5e0a6f8bc7dc/fphar-16-1604998-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/600b51048107/fphar-16-1604998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/36350eec6b34/fphar-16-1604998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/cfc22045c2bb/fphar-16-1604998-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd4/12310647/5e0a6f8bc7dc/fphar-16-1604998-g004.jpg

相似文献

1
Progress of targeted FOX family therapy in ovarian cancer.卵巢癌中靶向FOX家族治疗的进展
Front Pharmacol. 2025 Jul 17;16:1604998. doi: 10.3389/fphar.2025.1604998. eCollection 2025.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients.从原发性肿瘤和患者来源的异种移植肿瘤建立的类器官模型反映了卵巢癌患者的铂敏感性。
bioRxiv. 2025 May 2:2024.06.28.601283. doi: 10.1101/2024.06.28.601283.
6
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Hail Lifestyle Medicine consensus position statement as a medical specialty: Middle Eastern perspective.欢呼将生活方式医学作为一门医学专业的共识立场声明:中东视角。
Front Public Health. 2025 Jun 20;13:1455871. doi: 10.3389/fpubh.2025.1455871. eCollection 2025.
9
Unveiling the Diagnostic Significance of Calprotectin in Serous Ovarian Carcinoma.揭示钙卫蛋白在浆液性卵巢癌中的诊断意义。
Life (Basel). 2025 Jul 8;15(7):1080. doi: 10.3390/life15071080.
10
Pediatric Diffuse High-Grade Gliomas: A Comprehensive Review Of Ad-vanced Methods Of Diagnosis And Treatment.小儿弥漫性高级别胶质瘤:诊断与治疗先进方法的全面综述
Curr Cancer Drug Targets. 2025 Jun 30. doi: 10.2174/0115680096365252250618115641.

本文引用的文献

1
Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR-Cas9.通过CRISPR-Cas9破坏FOXM1调控区域可抑制卵巢癌的肿瘤进展。
Drug Dev Res. 2025 Feb;86(1):e70049. doi: 10.1002/ddr.70049.
2
Autophagy mediated by ROS-AKT-FoxO pathway is required for intestinal regeneration in echinoderms.由ROS-AKT-FoxO途径介导的自噬是棘皮动物肠道再生所必需的。
Cell Commun Signal. 2025 Jan 7;23(1):8. doi: 10.1186/s12964-024-01993-0.
3
Analysis of frequency changes in CD8 regulatory T cell subsets in peripheral blood of individuals with type 1 diabetes.
1型糖尿病患者外周血中CD8调节性T细胞亚群频率变化分析。
Diabetol Metab Syndr. 2024 Dec 19;16(1):305. doi: 10.1186/s13098-024-01549-9.
4
Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.前列腺癌细胞来源的外泌体 ZNF667-AS1 通过与 U2AF1 结合减少 TGFBR1 mRNA 的稳定性,从而抑制 Treg 扩增和 DTX 耐药。
Mol Med. 2024 Oct 18;30(1):179. doi: 10.1186/s10020-024-00947-z.
5
Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.靶向 FOXP3+Tregs 以增强抗肿瘤免疫。
Front Immunol. 2024 Aug 21;15:1426657. doi: 10.3389/fimmu.2024.1426657. eCollection 2024.
6
Prediction and assessment of deleterious and disease causing nonsynonymous single nucleotide polymorphisms (nsSNPs) in human gene: An study.人类基因中有害和致病非同义单核苷酸多态性(nsSNPs)的预测与评估:一项研究。
Heliyon. 2024 Jun 15;10(12):e32791. doi: 10.1016/j.heliyon.2024.e32791. eCollection 2024 Jun 30.
7
FOXC1 and FOXC2 Ablation Causes Abnormal Valvular Endothelial Cell Junctions and Lymphatic Vessel Formation in Myxomatous Mitral Valve Degeneration.FOXC1 和 FOXC2 缺失导致黏液样二尖瓣退行性变中的瓣膜内皮细胞连接异常和淋巴管形成。
Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):1944-1959. doi: 10.1161/ATVBAHA.124.320316. Epub 2024 Jul 11.
8
CD147 facilitates cisplatin resistance in ovarian cancer through FOXM1 degradation inhibition.CD147通过抑制FOXM1降解促进卵巢癌顺铂耐药。
Genes Dis. 2024 Mar 24;11(5):101277. doi: 10.1016/j.gendis.2024.101277. eCollection 2024 Sep.
9
FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.FOXP4 介导的 PTK7 诱导激活 Wnt/β-连环蛋白通路并促进卵巢癌发展。
Cell Death Dis. 2024 May 13;15(5):332. doi: 10.1038/s41419-024-06713-7.
10
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells.NB 化合物是高效的 FOXM1 抑制剂,可用于治疗高级别浆液性卵巢癌细胞。
J Ovarian Res. 2024 May 4;17(1):94. doi: 10.1186/s13048-024-01421-4.